Absci Corp (ABSI) Financial Statements
Industry: Commercial Physical & Biological Research (Services)
In fiscal 2025, Absci reported revenue of $2.8M, down 38.2% from $4.5M the year before. Net income was -$115.2M (a -4113.7% net margin), or -$0.84 per diluted share. Operating margin was -4297.0%. Operating activities generated -$92.9M of cash, leaving -$94.0M of free cash flow. At fiscal year end, Absci held $216.3M in total assets against $26.8M in total liabilities, including $20.0M of cash and equivalents.
Open the full interactive Absci financials → Quarterly statements, key ratios, valuation history and price charts.
Absci Key Stats
| Share Price | $9.10 |
|---|---|
| Market Cap | $1.43B |
| Revenue YoY Growth | -38.2% |
| 52-Week Range | $2.30 – $11.62 |
| Shares Outstanding | 157.5 million (basic, 2026 Q2) |
Absci Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $4.8M | $5.7M | $5.7M | $4.5M | $2.8M |
| Operating Income | -$75.2M | -$106.8M | -$115.5M | -$108.9M | -$120.3M |
| Pre-Tax Income | -$109.9M | -$105.4M | -$110.5M | -$103.0M | -$115.1M |
| Income Tax | -$8.9M | -$461,000 | $100,000 | $70,000 | $69,000 |
| Net Income | -$101.0M | -$104.9M | -$110.6M | -$103.1M | -$115.2M |
| Diluted EPS | -$2.08 | -$1.15 | -$1.20 | -$0.94 | -$0.84 |
Absci Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $378,000 | $650,000 | $215,000 | $318,000 |
| Net Income | -$28.7M | -$29.6M | -$29.6M | -$33.2M |
| Diluted EPS | -$0.20 | -$0.22 | -$0.19 | -$0.21 |
Absci Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $252.6M | $60.0M | $72.4M | $41.2M | $20.0M |
| Current Assets | $273.1M | $186.9M | $120.6M | $133.8M | $149.6M |
| Total Assets | $426.2M | $321.0M | $217.3M | $213.6M | $216.3M |
| Current Liabilities | $33.9M | $30.3M | $29.6M | $28.7M | $22.8M |
| Total Long-Term Debt | $3.5M | $10.9M | $7.9M | $4.0M | — |
| Total Liabilities | $60.1M | $46.6M | $41.1M | $34.5M | $26.8M |
| Shareholders' Equity | $366.1M | $274.4M | $176.2M | $179.1M | $189.4M |
Absci Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$60.6M | -$81.3M | -$64.6M | -$72.4M | -$92.9M |
| Cash From Investing | -$67.4M | -$127.0M | $81.9M | -$41.6M | -$50.2M |
| Cash From Financing | $336.2M | $5.2M | -$4.5M | $82.5M | $105.9M |
| Free Cash Flow | -$98.6M | -$97.5M | -$65.5M | -$72.8M | -$94.0M |
Figures from Absci's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Absci financials page for every line item.
Absci Company Profile
| Ticker | ABSI |
|---|---|
| Exchange | Nasdaq |
| Industry | Commercial Physical & Biological Research (Services) |
| Headquarters | Vancouver, Washington |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company, emerging growth company |
| SEC CIK | 0001672688 |
Frequently Asked Questions
What was Absci's revenue in fiscal 2025?
Absci (ABSI) reported revenue of $2.8M for fiscal 2025.
What is Absci's annual revenue history?
Absci's annual revenue by fiscal year: 2021: $4.8M; 2022: $5.7M; 2023: $5.7M; 2024: $4.5M; 2025: $2.8M.
What was Absci's net income in fiscal 2025?
Absci reported net income of -$115.2M for fiscal 2025.
What was Absci's earnings per share (EPS) in fiscal 2025?
Absci's diluted EPS was -$0.84 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Absci generate in fiscal 2025?
Absci generated -$94.0M of free cash flow in fiscal 2025.
What was Absci's revenue last quarter?
In its most recent reported quarter (2026 Q2), Absci reported revenue of $318,000.
How many shares of Absci are outstanding?
Absci reported a weighted average of 157.5 million basic shares outstanding in 2026 Q2.
What is Absci's market cap?
Based on its latest closing price, Absci (ABSI) has a market capitalization of about $1.43B.
When does Absci's fiscal year end?
Absci's fiscal year end, as registered with the SEC, is December 31.
Where is Absci headquartered?
Absci lists its business address in Vancouver, Washington in its SEC filings.
Absci Competitors & Similar Companies
See all 12 Commercial Physical & Biological Research (Services) companies →